Hearing Aids and Health Education to Study Hearing Loss and Memory Decline
Compares hearing aids with health education in middle-aged adults with early hearing loss.
Key facts
- Who runs it
- Columbia University
- Where
- New York, United StatesSee the site
- Trial code
- Registry title
- Early Age-Related Hearing Loss Investigation (EARHLI)
- Status
- Recruiting
- People taking part
- 150 people, planned
- Started
- 1 Aug 2024
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 2 groups
- Treatments tested
- Hearing Intervention
- Health Education Intervention
- Record updated
- 12 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 55 to 75 with mild to moderate hearing loss and mild memory problems (amnestic mild cognitive impairment). They will get either a hearing intervention with hearing aids or a health education program.
- Age
- 55 to 75 years
- Sex
- All sexes
- Disease stage
- Hearing loss that began in adulthood, mild to moderate (pure tone average 20 dB to 55 dB HL in the better hearing ear), that hearing aids can help (word recognition in quiet ≥ 60% in the better ear). Also amnestic mild cognitive impairment (MMSE2 score >23, CDR global score 0.5, low Logical Memory II score for years of education).
- Earlier treatment
- People who use hearing aids now, or used them regularly in the past 6 months, cannot join.
Main reasons for not taking part
- Hearing loss from birth, from a known gene change, or starting before age 45
- A previous dementia diagnosis
- Disability in 2 or more activities of daily living
- Not willing to wear hearing aids at least 8 hours a day
- Medical reason not to use hearing aids, such as an actively draining ear
The registry criteria, word for word
Show all 16 criteriaShow less
Who can take part
- Age 55-75 years of age
- Adult-onset hearing loss of approximately mild to moderate in severity (4-frequency 0.5, 1, 2, 4 kHz pure tone average 20 dB to 55 dB HL in better hearing ear)
- Aidable hearing loss, defined by word recognition score in quiet ≥ 60% in better hearing ear
- Amnestic mild cognitive impairment (MCI) defined by Mini-Mental State Exam (MMSE2) score >23, Clinical Dementia Rating (CDR) global score equivalent = 0.5, and ADNI3 criteria of Logical Memory II score of ≤6 if 0-7 years of education, ≤9 if 8-15 years, and ≤11 if ≥16 years
- Availability of a study partner (informant) for the administration of the cognitive screen and the ADCS-Activities of Daily Living-Prevention Instrument (ADCS-ADL-PI)
- Community-dwelling
- Fluent in English or Spanish
- Availability of participant in area for study duration
Who cannot take part
- Prior dementia diagnosis
- Current or previous consistent hearing aid user (such as utilization of hearing aids within the past 6 months beyond brief trials)
- Corrected vision impairment (worse than 20/63 on MNRead Acuity Chart in worse eye)
- Self-reported congenital hearing loss, known genetic mutation-related hearing loss, or hearing loss onset before middle age (<45 years old)
- Reported disability in ≥ 2 activities of daily living (ADLs)
- Unwillingness to wear hearing aids regularly (≥8 hours/day)
- Medical contraindications to the use of hearing aids (e.g., actively draining ear)
- Untreatable conductive hearing loss with air-bone gap > 15 dB in two or more contiguous octave frequencies in both ears
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 55 and 75 years old?
Where in United States
- Columbia University Medical CenterNew York, United StatesContact: Larry TapiaTaking people
About the trial
What the trial wants to find out
Early Age-Related Hearing Loss Investigation (EARHLI) is a single site study that will randomize late middle age adults to either a hearing intervention (including hearing aids) or a health education intervention. Participants will be followed for 1 year. This study will provide information on reducing cognitive decline in those at risk for Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD).
The 2 groups in the trial
- Hearing InterventionOther group
Participants will receive 4 sessions across 8 weeks with a later booster session and hearing aid fitting. Each session will take \~75 minutes.
- Health Education InterventionOther group
Participants will receive a modified health education program on healthy aging. It will match the number and length of sessions as the hearing intervention, including compliance/phone checks. Participants will be on a waitlist to obtain hearing aids without fee at the end of their 12-month participation.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Early Age-Related Hearing Loss Investigation (EARHLI): A Randomized Controlled Trial to Assess the Mechanisms Linking Early Age-Related Hearing Loss and Alzheimer's Disease and Related Dementias
- Plain-language title
- Hearing Aids and Health Education to Study Hearing Loss and Memory DeclineGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT06174038, who can take part
- Publications
- Design and Methods of the Early Age-Related Hearing Loss Investigation Randomized Controlled Trial.Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology, 2024
- Record updated
- 12 August 2026